than having them concentrated in a foreign adversary such as China. The Chamber further supports using the CHIPS and Science Act (2022), which promotes the domestic production of semiconductor technology, as a model for the effort to ensure that Americans can drive technology and innovation in the production of pharmaceutical products and not be reliant on importing these products in the event of a global pandemic or other supply shortage.
Made with FlippingBook - professional solution for displaying marketing and sales documents online